RHO6 vs RO: Side-by-Side Comparison
Compare Roche Holding AG (RHO6) and Roche Holding AG (RO) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | RHO6 | RO |
|---|---|---|
| Company | Roche Holding AG | Roche Holding AG |
| Country / Exchange | Switzerland · STU | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | — | CHF 267.01B |
| P/E ratio | — | 20.9 |
| Dividend yield | — | 2.89% |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 63.36B | CHF 63.36B |
| Revenue growth YoY | +1.5% | +1.5% |
| Net income | EUR 12.88B | CHF 12.88B |
| Gross margin | 73.7% | 73.7% |
| Diluted EPS | 16.04 | 16.04 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.